1-Bromo-2-methylpropane → (S)-tert-Butyl 1-isobutyl-2-oxoazepan-3-ylcarbamate
Reaktionsgleichung
[O:1]=[C:2]1[C@@H:8]([NH:9][C:10](=[O:16])[O:11][C:12]([CH3:15])([CH3:14])[CH3:13])[CH2:7][CH2:6][CH2:5][CH2:4][NH:3]1.[H-].[Na+].[CH2:19](Br)[CH:20]([CH3:22])[CH3:21].[NH4+].[Cl-]>CN(C=O)C>[CH2:19]([N:3]1[CH2:4][CH2:5][CH2:6][CH2:7][C@H:8]([NH:9][C:10](=[O:16])[O:11][C:12]([CH3:13])([CH3:15])[CH3:14])[C:2]1=[O:1])[CH:20]([CH3:22])[CH3:21]Komponenten
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
To a solution of (S)-tert-butyl 2-oxoazepan-3-ylcarbamate (116 mg, 0.510 mmol) in DMF (2 mL) at 0° C. was added sodium hydride (60% in oil, 23 mg, 0.57 mmol) in 2 portions. After stirring for 5 min, isobutyl bromide (175 mg, 1.28 mmol) was added to the reaction mixture and the mixture was stirred at rt for 20 h. Saturated aqueous NH4Cl (2 mL) was added to the mixture and crude product was extracted with methylene chloride (3 mL) and the combined organic layers were dried (Na2SO4) and concentrated. The crude product was purified using silica gel chromatography to afford (S)-tert-Butyl 1-isobutyl-2-oxoazepan-3-ylcarbamate (46.4 mg, 0.247 mmol, 49% yield). Anal. Calcd. for C15H28N2O3 m/z 284.2. found: 285.2 (M+H)+; 1H NMR (400 MHz, DMSO-d6) δ ppm 6.44 (d, J=6.64 Hz, 1H), 4.26 (t, J=9 Hz, 1H), 3.57-3.50 (m, 1H), 3.26-3.17 (m, 2H), 3.10-3.05 (m, 1H), 1.84-1.62 (m, 5H), 1.37 (s, 9H), 1.34-1.24 (m, 2H), 0.84-0.80 (m, 6H).
Aufarbeitung
- stirringthe mixture was stirred at rt for 20 h
- extractionwas extracted with methylene chloride (3 mL)
- dry with materialthe combined organic layers were dried (Na2SO4)
- concentrationconcentrated
- customThe crude product was purified
Quellen und Nachweise
- ORD-Eintrag
- ord-7bb752e53f454cb3869c006670397167
- Quelldatensatz
- uspto-grants-2016_05
- Patentnummer
- US09346852B2
Notizen zur Reaktion
Wird geladen…